Gene · 10507
Papers1,823
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,823
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control. | J Adv Res | 2026 | 40073972 | PubTator, text mining | PubMed |
| Role of Galectin-1 in the Pathogenesis of Melanoma. | J Cancer Sci Clin Ther | 2025 | 41918780 | PubTator, text mining | PubMed |
| Angiogenic regulation of dental pulp stem cells. | Front Dent Med | 2025 | 41458173 | PubTator, text mining | PubMed |
| Immunological profile and its clinical implications in pediatric infectious mononucleosis. | Front Pediatr | 2025 | 41321447 | PubTator, text mining | PubMed |
| [The Role of Sema4D in Immune Abnormalities Mediated by IgA Secreted by B Lymphocytes in Children with Henoch-Schonlein Purpura]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41234103 | PubTator, text mining | PubMed |
| IGF2BP3 promotes acute myeloid leukemia cell progression by regulating Semaphorin 4D stability in an m6A-dependent manner. | Leuk Res | 2025 | 41187599 | PubTator, text mining | PubMed |
| Association between glucose peak time in oral glucose tolerance test and insulin secretion during pregnancy. | J Matern Fetal Neonatal Med | 2025 | 41161863 | PubTator, text mining | PubMed |
Re-Evaluating the Treatment Plan for Diabetic Macular Edema Based on Early Identification of Response and Possible Biochemical Predictors of Non-Response After the First Intravitreal Ranibizumab Injection. | Biomedicines | 2025 | 41153721 | PubTator, text mining | PubMed |
| Meeting abstracts of the GISM Annual Meeting 2025. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132511 | PubTator, text mining | PubMed |
| The Effects of CD100 Stimulation on Primary Human Hepatocytes (PHHs) and Its Implications in HBV-Related Liver Cirrhosis. | J Gastroenterol Hepatol | 2025 | 41120226 | PubTator, text mining | PubMed |
| White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis. | Cells | 2025 | 41002375 | PubTator, text mining | PubMed |
| Nanomaterial-Based Anti-Angiogenic Gene Therapy for Retinal Neovascular Diseases: Mechanistic Insights and Preclinical Advances. | Int J Nanomedicine | 2025 | 40989889 | PubTator, text mining | PubMed |
| Deciphering the Heterogeneity of Pancreatic Cancer: DNA Methylation-Based Cell Type Deconvolution Unveils Distinct Subgroups and Immune Landscapes. | Epigenomes | 2025 | 40981070 | PubTator, text mining | PubMed |
| Genome-Wide Identification of Microglia-Related RNA-Binding Proteins and Regulated Alternative Splicing in Spinal Cord Injury. | ACS Omega | 2025 | 40893312 | PubTator, text mining | PubMed |
| Colorimetric Food Freshness Indicators for Intelligent Packaging: Progress, Shortcomings, and Promising Solutions. | Foods | 2025 | 40870726 | PubTator, text mining | PubMed |
| Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes a Distinct Semaphorin-Cytokine Immune Signature in Severe Community-Acquired Pneumonia. | Int J Mol Sci | 2025 | 40869413 | PubTator, text mining | PubMed |
| Preventing Skeletal-Related Events in Newly Diagnosed Multiple Myeloma. | Cells | 2025 | 40862742 | PubTator, text mining | PubMed |
| A novel and robust feature selection method with FDR control for omics-wide association analysis. | PLoS One | 2025 | 40845052 | PubTator, text mining | PubMed |
| DNA methylation of food sensitization in a French-Canadian population. | Clin Epigenetics | 2025 | 40820203 | PubTator, text mining | PubMed |
| Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis. | Nat Commun | 2025 | 40818975 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10507/papers?page=3